Its not like they flat out tell us or anything like that eh 🤣

THE BIOTERRORISM "NEW WORLD ORDER"

CHECK THE DOCUMENTS ON THIS POST! THERE IS SOMETHING THE NEWS ISN'T TELLING YOU ABOUT! https://www.facebook.com/share/v/16RBPEtMM4p/ . Agile Nations Charter In November 2020, seven countries signed on to the Agile Nations Charter, establishing Agile Nations as a forum for countries to collaborate on creating a global regulatory environment in which innovation can thrive. Member countries include:

Canada Denmark Italy Japan Singapore the United Arab Emirates the United Kingdom The Organisation for Economic Cooperation and Development (OECD) and the World Economic Forum (WEF) also participate as observers.

Priority areas for cooperation are:

data and communications transportation medical diagnosis and treatment clean technology legal and professional services pro-innovation regulatory approaches Workplan In October 2021, member nations approved the first Agile Nations work programme of 10 projects.

Under this workplan, Canada will work with Agile Nations partners to address issues ranging from cyber security and digital technologies to the use of regulatory experimentation. These projects involve sharing ideas, testing new solutions and identifying opportunities for regulators to better support innovative industries in introducing and scaling new technologies.

Participating departments and agencies include:

Health Canada Innovation, Science and Economic Development Canada Standards Council of Canada Transport Canada Treasury Board of Canada Secretariat https://www.canada.ca/en/government/system/laws/developing-improving-federal-regulations/modernizing-regulations/agile-nations.html . biodigital convergence, defined as the merging of biological and digital technologies into a unified domain. This convergence is characterized by three emerging forms: the full physical integration of biological and digital entities, the coevolution of technologies in both fields, and the conceptual convergence of biological and digital systems.

Canada is at the forefront of international standardization for this field, leading the IEC Standardization Evaluation Group 12 to map market trends and regulatory needs. Recent reports highlight that this convergence is already a present reality influencing data, genomics, and critical systems, with significant cross-cutting policy implications for healthcare, food security, national security, and intellectual property. https://search.brave.com/search?q=canada+biodigital+convergence&source=android&conversation=09c1a9cd21c08f82179381f881d67dc2e507 . China is a global leader in biodigital convergence, leveraging massive state investment to integrate biology with digital technologies like AI, quantum computing, and 5G/6G. The Chinese government prioritizes this convergence through strategic initiatives such as the China Brain Project (funded with over $1 billion from 2016 to 2030), which advances brain-computer interfaces (BCIs) and neural control, and the Graphene Flagship supporting neural tech.

Key areas of Chinese dominance include:

Supercomputing: China leads the world with 186 research centers on the Top 500 list, significantly ahead of the US, enabling high-speed genomic data analysis. Genomics and Surveillance: Chinese firms like BGI Genomics sequence millions of genomes at low costs (claimed $100 per genome in 2020), feeding AI-driven health platforms and predictive policing DNA databases. Biotechnology: China pioneered the birth of the first CRISPR-edited babies and is heavily investing in mRNA vaccine development and lab-grown food production to secure food and health resilience. Smart Cities: State-backed initiatives integrate biodigital surveillance into urban grids, using data from health grids and IoT applications to enhance societal control and efficiency. This strategic focus positions China as a primary driver of the "bioinformational capitalism" model, where biological systems are engineered and managed through advanced digital infrastructure. https://search.brave.com/search?q=china+biodigital+convergence&source=android&conversation=09c1a703f69dc0adc62549e1921fa38d5b28 . Biodigital convergence in the European Union is defined as the fusion of biology, digital technologies, and cognitive science, driven by initiatives like the European Green Deal and the European Health Data Space. This convergence integrates fields such as synthetic biology, AI, and nanotechnology to support the bioeconomy, aiming for climate neutrality by 2050 while raising significant ethical, privacy, and regulatory questions.

Key EU Frameworks and Projects

European Green Deal: Establishes the legislative framework for a carbon-neutral bioeconomy, promoting renewable biobased materials and industrial innovation. European Health Data Space (EU 2025/327): Creates a binding legal framework for cross-border health data access, with genomic data provisions fully operational by March 26, 2031. IEC Standardization: The IEC Standardization Evaluation Group 12 (SEG 12) assesses bio-digital convergence, focusing on areas like biosensors, human augmentation, and environmental bioengineering. Research Initiatives: EU-funded projects like DESTINATION (AI-enabled RNA nanotechnology) and Nanonets2Sense explore medical applications and cellular control. Implications and Governance

Surveillance and Identity: The EU Digital Identity Wallet links legal identity with health records, creating infrastructure that combines genomic data with digital credentials. Policy Challenges: Governments are addressing risks such as cross-border governance, intellectual property disputes, and the blurring of natural and synthetic systems. Ethical Concerns: Analysts highlight the potential for biodigital convergence to redefine human identity, necessitating robust ethical guidelines and standardization to manage risks in healthcare and agriculture. https://search.brave.com/search?q=European+Union+BIODIGITAL+CONVERGENCE&source=web&conversation=09c10d25884607cc72489a78d8e973648657 . The United States has established biodigital convergence as a strategic priority, highlighted by the March 2023 White House Executive Order on Advancing Biotechnology and Biomanufacturing, which set national objectives for human health, agriculture, and climate change solutions. This convergence is further supported by the National Science Foundation’s focus on the Nano-Bio-Info-Cogno (NBIC) Paradigm, which drives research into the unified ecosystem of genomic and information science.

Key developments in the US biodigital landscape include:

Regulatory Approval: The FDA has begun approving bio-digital devices, such as brain-controlled prosthetics and smart implants, signaling mainstream readiness for bio-hybrid medical technologies. Data and Privacy: The convergence of biological and digital data is accelerating personalized medicine, while raising significant concerns regarding genomic privacy and the protection of sensitive health information. Economic Shift: There is a move toward decentralized biomanufacturing and synthetic biology, allowing for the production of goods like 3D-printed tissues and engineered organisms closer to the point of care. Investment: Venture capital for bio-digital startups surged significantly in recent years, with major tech firms establishing dedicated divisions to leverage the intersection of AI and biotechnology. https://search.brave.com/search?q=USA+biodigital+convergence&source=android&conversation=09c1e4c33ca83bdadf65d4030a2bab022d3c